Source: PharmaTech

iCardiac: iCardiac Launches New eCOA Platform

iCardiac Technologies has announced the launch of its new eCOA platform, QPoint. This platform looks to answer the growing demand for more efficient and innovative eCOA study services in drug development. Read the full release here iCardia

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Alex Zapesochny's photo - President & CEO of iCardiac

President & CEO

Alex Zapesochny

CEO Approval Rating

73/100

Read more